$ATLX

Fogassa Marc sold (to issuer) $238K of ATLX

Fogassa Marc (Chief Executive Officer) sold (to issuer) 55,555 shares of Atlas Lithium Corp (ATLX) at $4.28 ($0.24M total) on 2026-06-03 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · Fogassa Marc
Published Jun 6, 2026, 1:00 AM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jun 6, 2026, 1:03 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$ATLX
Neutral
medium confidence
Mentioned
$ATLX
Relevance
6/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$ATLXNeutralLow
01

Why it matters

Because it is pre-arranged and lacks accompanying fundamental updates, the trading impact is usually muted; the main value is confirming execution price and insider/issuer transaction mechanics.

02

Market read

A routine 10b5-1 insider sale datapoint for ATLX with likely minimal immediate price impact absent other catalysts.

03

What to watch

The filing does not clarify whether the issuer’s buyback program is expanding or contracting; comparing to prior Form 4 patterns could matter more than the single print.

Relevance 6/10Novelty 5/10Timing: Filed June 5; transaction dated June 3 (post-trade disclosure).

Background

The article is an SEC Form 4 insider transaction disclosure for Atlas Lithium, showing a sale to the issuer under a pre-arranged 10b5-1 plan.

Company-level read

Ticker impact

$ATLXNeutralMedium confidence
Context

Atlas Lithium CEO sold 55,555 shares to the issuer at $4.2803/share under a pre-arranged 10b5-1 plan, disclosed via Form 4.

Expected impact

Likely minimal near-term impact; any reaction should be small and fade unless accompanied by other news.

Evidence & confidence

This is an SEC Form 4 insider transaction with stated 10b5-1 pre-arrangement; the filing provides a datapoint (execution price/size) but no new operating or strategic information.

Market effects

Limited read-across to lithium/energy metals peers; this is company-specific insider execution without new sector catalyst.

None indicated; transaction is a US-listed microcap insider Form 4.

None indicated.

Counterpoint

If the sale-to-issuer structure is unusual for ATLX or the size is large relative to typical insider activity, it could be interpreted as near-term risk management rather than pure routine.

Key entities

  • Atlas Lithium Corp

    Subject company whose CEO/insider sold shares to the issuer under a 10b5-1 plan.

  • Fogassa Marc

    CEO, officer/director/10% owner who executed the sale to the issuer.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$ATLXMed

Atlas Lithium Receives Strong Product Demand; On Track for Commercial Production in 2027

Atlas Lithium (NASDAQ: ATLX) said its 100%-owned Neves Project is on track for first commercial production of lithium oxide concentrate in Q4 2027. The company plans about 150,000 tonnes per year and reported written product interest totaling over 3x capacity. It cited DFS economics of 145% after-tax IRR, 11-month payback, and $489 per tonne operating costs.

$ATLXMed

Atlas Lithium (NASDAQ: ATLX) said its 100% owned Neves Project in Brazil is on track for first commercial production of lithium oxide concentrate in Q4 2027

Atlas Lithium (NASDAQ: ATLX) said its 100% owned Neves Project in Brazil is on track for first commercial production of lithium oxide concentrate in Q4 2027. The company targets about 150,000 tonnes per year and reports written product interest totaling over three times capacity. It cites DFS economics of 145% after-tax IRR and 11-month payback, with operating costs of $489 per tonne.